These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1932573)

  • 1. Two-dimensional 1H-NMR study of antigen-antibody interactions: binding of synthetic decapeptides to an anti-acetylcholine receptor monoclonal antibody.
    Cung MT; Demange P; Marraud M; Tsikaris V; Sakarellos C; Papadouli I; Kokla A; Tzartos SJ
    Biopolymers; 1991 May; 31(6):769-76. PubMed ID: 1932573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic lactam analogues containing the main immunogenic region of Torpedo acetylcholine receptor.
    Detsikas E; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vatzaki E; Tzartos SJ
    Pept Res; 1993; 6(1):17-23. PubMed ID: 7679937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
    Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
    Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional 1H-NMR study of synthetic peptides containing the main immunogenic region of the Torpedo acetylcholine receptor.
    Cung MT; Marraud M; Hadjidakis I; Bairaktari E; Sakarellos C; Kokla A; Tzartos S
    Biopolymers; 1989 Jan; 28(1):465-78. PubMed ID: 2470436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies.
    Bellone M; Tang F; Milius R; Conti-Tronconi BM
    J Immunol; 1989 Dec; 143(11):3568-79. PubMed ID: 2584708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2D-NMR and molecular dynamics analysis of the Torpedo californica acetylcholine receptor alpha 67-76 fragment and of its [Ala76]-analogue.
    Cung MT; Tsikaris V; Demange P; Papadouli I; Tzartos SJ; Sakarellos C; Marraud M
    Pept Res; 1992; 5(1):14-24. PubMed ID: 1623299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.
    Barchan D; Balass M; Souroujon MC; Katchalski-Katzir E; Fuchs S
    J Immunol; 1995 Nov; 155(9):4264-9. PubMed ID: 7594584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and conformational study of biologically active photolabeled analogues of the main immunogenic region of the acetylcholine receptor.
    Theodorou V; Tsikaris V; Sakarellos-Daitsiotis M; Avramopoulou V; Kostelidou K; Tzartos SJ; Sakarellos C
    Biopolymers; 2000-2001; 56(1):37-46. PubMed ID: 11582576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of the complex between Torpedo acetylcholine receptor and anti-MIR Fab198.
    Konstantakaki M; Tzartos SJ; Poulas K; Eliopoulos E
    Biochem Biophys Res Commun; 2007 May; 356(3):569-75. PubMed ID: 17376405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor.
    Trinh VB; Foster AJ; Fairclough RH
    Mol Immunol; 2014 May; 59(1):79-90. PubMed ID: 24491490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional NMR studies of the interactions between a peptide of cholera toxin and monoclonal antibodies.
    Anglister J; Scherf T; Zilber B; Levy R
    Biopolymers; 1995; 37(6):383-9. PubMed ID: 8589243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
    Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.
    Campbell AP; Wong WY; Houston M; Schweizer F; Cachia PJ; Irvin RT; Hindsgaul O; Hodges RS; Sykes BD
    J Mol Biol; 1997 Mar; 267(2):382-402. PubMed ID: 9096233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of the antibody-bound tyrosine phosphorylation site of the nicotinic acetylcholine receptor beta-subunit in its phosphorylated and nonphosphorylated states.
    Phan-Chan-Du A; Hemmerlin C; Krikorian D; Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Marinou M; Thureau A; Cung MT; Tzartos SJ
    Biochemistry; 2003 Jun; 42(24):7371-80. PubMed ID: 12809492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the mAb 383C epitope to alpha 2(187-199) of the Torpedo acetylcholine receptor on the three-dimensional model.
    Fairclough RH; Twaddle GM; Gudipati E; Stone RJ; Richman DP; Burkwall DA; Josephs R
    J Mol Biol; 1998 Sep; 282(2):301-15. PubMed ID: 9735289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.